✦ LIBER ✦

Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer

✍ Scribed by Matsuyama, Hideyasu; Shimabukuro, Tomoyuki; Hara, Isao; Kohjimoto, Yasuo; Suzuki, Kazuhiro; Koike, Hidekazu; Uemura, Hirotsugu; Hayashi, Taiji; Ueno, Munehisa; Kodaira, Kiichiro; Tomita, Yoshihiko; Sakurai, Toshihiko; Shimizu, Nobuaki

Book ID: 121599857
Publisher: Springer
Year: 2013
Tongue: English
Weight: 264 KB
Volume: 19
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-013-0638-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prediction of bone metastases by combina

Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer

✍ Choichiro Ozu; Jun Nakashima; Yutaka Horiguchi; Mototsugu Oya; Takashi Ohigashi; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Weekly low-dose docetaxel combined with

Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer

✍ Hatano, Koji; Nishimura, Kazuo; Nakai, Yasutomo; Yoshida, Takahiro; Sato, Motota 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 292 KB

430 Dose finding of inecalcitol, a new V

430 Dose finding of inecalcitol, a new VDR agonist, in combination with docetaxel–prednisone regimen for castrate-resistant prostate cancer (HRPC) patients (pts)

✍ J. Medioni; G. Deplanque; J.M. Ferrero; T. Maurina; J.M. Rodier; E. Raymond; G. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Phase I trial with a combination of doce

Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer

✍ Jianqing Lin; Victoria J. Sinibaldi; Michael A. Carducci; Samuel Denmeade; Danny 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 296 KB

7028 Dasatinib and docetaxel combination

7028 Dasatinib and docetaxel combination treatment for patients with metastatic castration-resistant prostate cancer (CRPC): analysis of Study CA180–086

✍ Araujo, J.; Mathew, P.; Armstrong, A.J.; Braud, E.L.; Posadas, E.; Lonberg, M.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A phase I study of oral panobinostat alo

A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer

✍ Dana Rathkopf; Bryan Y. Wong; Robert W. Ross; Aseem Anand; Erika Tanaka; Margare 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 378 KB